Bank of America (TMCI) reports 3.53M shares, 5.5% ownership

Rhea-AI Filing Summary

Bank of America Corporation filed a Schedule 13G reporting beneficial ownership of 3,533,774 shares of Treace Medical Concepts, Inc. Common Stock. The filing states this equals 5.5% of the class based on 64,590,503 outstanding shares as of February 20, 2026, per the issuers Form 10-K. The Schedule 13G lists shared voting and dispositive power over the reported shares and identifies related subsidiaries (BofA Securities, Inc.; Bank of America, N.A.; Merrill Lynch International) as relevant holders.

Insights

Institutional Ownership Analyst

Large institutional stake disclosed with shared voting/control via subsidiaries.

The filing reports 3,533,774 shares held with shared voting and dispositive power. The ownership percentage is calculated against February 20, 2026 outstanding share data from the issuers Form 10-K. The statement attributes holdings to Bank of America Corporation and its specified subsidiaries.

Because the position is disclosed on a Schedule 13G, the filing signals a passive institutional holding rather than an activist intent. Subsequent filings may show changes in voting or disposition status if the holder changes its intent or trades the position.

Key Figures

Reported shares owned: 3,533,774 shares Percent of class: 5.5% Outstanding shares used: 64,590,503 shares +4 more

7 metrics

Reported shares owned 3,533,774 shares Schedule 13G filing

Percent of class 5.5% Calculated using outstanding shares from Form 10-K as of <date>February 20, 2026</date>

Outstanding shares used 64,590,503 shares Issuers Form 10-K reporting totals as of <date>February 20, 2026</date>

Shared voting power 3,533,774.00 Item 4(ii) of Schedule 13G

Sole voting power 0.00 Item 4(i) of Schedule 13G

Filing signature date 05/14/2026 Signature by authorized signatory on Schedule 13G

CUSIP 89455T109 Common Stock CUSIP reported on the cover

Key Terms

Schedule 13G, beneficial ownership, shared dispositive power, parent holding company filing

4 terms

Schedule 13G regulatory

"filed a Schedule 13G reporting beneficial ownership of 3,533,774 shares"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

beneficial ownership financial

"Amount beneficially owned: 3,533,774.00 (b) Percent of class: 5.5%"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

shared dispositive power regulatory

"Shared power to dispose or to direct the disposition of: 3,533,774.00"

parent holding company filing regulatory

"filed by Bank of America Corporation on behalf of itself and its wholly owned subsidiaries"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

TREACE MEDICAL CONCEPTS, INC.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

89455T109

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 89455T109

1

Names of Reporting Persons

BANK OF AMERICA CORP /DE/

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 3,533,774.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 3,533,774.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,533,774.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.5 %

12

Type of Reporting Person (See Instructions)

HC

Comment for Type of Reporting Person: The beneficial ownership calculation relies on the 64,590,503 outstanding shares disclosed in the Form 10-K by the issuer on February 27, 2026, which reports share totals as of February 20, 2026.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: TREACE MEDICAL CONCEPTS, INC.
(b)	Address of issuer's principal executive offices: 100 PALMETTO PARK PLACE, PONTE VEDRA, FLORIDA, 32081.
Item 2.
(a)	Name of person filing: BANK OF AMERICA CORP /DE/
(b)	Address or principal business office or, if none, residence: 100 N TRYON ST CHARLOTTE, NC 28255
(c)	Citizenship: Delaware
(d)	Title of class of securities: Common Stock
(e)	CUSIP Number(s): 89455T109
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 3,533,774.00
(b)	Percent of class: 5.5%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0.00
	(ii) Shared power to vote or to direct the vote: 3,533,774.00
	(iii) Sole power to dispose or to direct the disposition of: 0.00
	(iv) Shared power to dispose or to direct the disposition of: 3,533,774.00
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. This statement on Schedule 13G is being filed by Bank of America Corporation on behalf of itself and its wholly owned subsidiaries BofA Securities, Inc., a broker dealer registered under section 15 of the Act (15 U.S.C. 78o); Bank of America N.A., a bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); and Merrill Lynch International, a non-U.S. institution in accordance with section 240.13d-1(b)(1)(ii)(J).
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

BANK OF AMERICA CORP /DE/

Signature:	/s/ Monica Yako
Name/Title:	Authorized Signatory
Date:	05/14/2026

FAQ

What stake does Bank of America report in TMCI?

Direct answer: Bank of America reports beneficial ownership of 3,533,774 shares in TMCI. Supporting context: The filing states this equals 5.5% of the class using 64,590,503 outstanding shares disclosed as of February 20, 2026 in the issuers Form 10-K.

Does the Schedule 13G indicate who controls the TMCI shares?

Direct answer: The filing shows shared voting and shared dispositive power over the reported shares. Supporting context: It lists BofA Securities, Inc.; Bank of America, N.A.; Merrill Lynch International as related subsidiaries acting under Bank of America Corporation.

Is Bank of Americas filing a Schedule 13G or 13D for TMCI?

Direct answer: The filing is a Schedule 13G, which is typically used for passive institutional holdings. Supporting context: Schedule 13G is shown on the cover and the signature block is dated 05/14/2026 under an authorized signatory for Bank of America Corporation.

What outstanding share count does the filing use to calculate the 5.5%?

Direct answer: The calculation uses 64,590,503 outstanding shares disclosed in the issuers Form 10-K. Supporting context: That Form 10-K reported share totals as of February 20, 2026, which the Schedule 13G cites for the percentage computation.

Does the Schedule 13G say Bank of America has sole voting power in TMCI?

Direct answer: No; the filing reports 0.00 sole voting power and 3,533,774 shared voting power. Supporting context: Item 4 lists sole power as 0.00 and shared voting power and shared dispositive power as 3,533,774.00.